Genetically determined in all ethnicities, some researchers are now suggesting all patients should be measured for lipoprotein (a) levels at least once in their lifetime.
Quebec health institute updates its screening checklist to help front-line clinicians assess requests for health check-ups and reduce the number of unnecessary consultations.
Study examines the comparative cardiovascular efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes.